ArticleMolecular & cellular proteomics : MCP2013

Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.

Teresa Cabezón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.